omalizumab
novartis,roche
['optima']
1) dr dinesh de alwis gives a very thoughtful talk on interpreting response to #cancer #immunotherapy/&amp; considerations for optimal dose finding &amp; decision making based on phase 1 data/i agree! need better use ph1 data! #sitc2022 #sitc22 #finishcancer 